Using cash incentives to improve health for African Americans with diabetes
Conditional Cash Transfer Intervention to Improve Health Outcomes among Inner-City African Americans with T2DM
This study is looking at how giving cash rewards for healthy activities can help African Americans with type 2 diabetes living in city neighborhoods improve their health and manage stress from poverty and racism.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | State University of New York at Buffalo NIH-funded |
| Lab location | 1 site (Amherst, United States) |
| Project ID | NIH-11187675 on NIH RePORTER |
What this research studies
This research investigates how conditional cash transfers can improve health outcomes for African Americans living in inner-city areas who have type 2 diabetes. By providing financial incentives tied to health-related activities, the study aims to alleviate the chronic stress caused by poverty and structural racism. Participants will be engaged in a program that encourages healthier behaviors and addresses barriers to health, such as food insecurity and limited access to healthcare. The approach is grounded in community-based insights and aims to create a supportive environment for better health management.
Who could benefit from this research
Good fit: Ideal candidates for this research are African American adults aged 21 and older who are living with type 2 diabetes and facing socioeconomic challenges.
Not a fit: Patients who do not have type 2 diabetes or those who do not identify as African American may not receive benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved health outcomes and quality of life for African Americans with type 2 diabetes.
How similar studies have performed: Previous research has shown that cash transfer programs can positively impact health behaviors and outcomes, suggesting potential success for this approach.
Where this research is happening
Amherst, United States
- State University of New York at Buffalo — Amherst, United States (Active)
Researchers
- Principal investigator: Campbell, Jennifer Annette — State University of New York at Buffalo
- Study coordinator: Campbell, Jennifer Annette
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.